August 5, 2025MetabolitesOpen Access

Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Experiment reveals galacto-oligosaccharides enhance Bifidobacterium and SCFA production in adults, suggesting prebiotic potential.

GOS were effective at modulating the gut microbiome at low doses, particularly enhancing Bifidobacterium species.
The study utilized ex vivo SIFR® technology to assess microbiome responses, distinguishing it from past in vitro approaches.
Significant production of short-chain fatty acids, especially acetate and butyrate, was observed starting from the lowest tested GOS dose.
These findings indicate that lower doses of prebiotics can still offer substantial health benefits, improving dietary flexibility.

Harthoorn et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 5, 2025MetabolitesOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Experiment reveals galacto-oligosaccharides enhance Bifidobacterium and SCFA production in adults, suggesting prebiotic potential.

GOS were effective at modulating the gut microbiome at low doses, particularly enhancing Bifidobacterium species.
The study utilized ex vivo SIFR® technology to assess microbiome responses, distinguishing it from past in vitro approaches.
Significant production of short-chain fatty acids, especially acetate and butyrate, was observed starting from the lowest tested GOS dose.
These findings indicate that lower doses of prebiotics can still offer substantial health benefits, improving dietary flexibility.

Harthoorn et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark